Hannah Chang, MD, PhD


Hannah H. Chang, M.D., Ph.D. joined 5AM Ventures as an Associate in 2014 from The Boston Consulting Group, where she was a Project Leader and a member of the Health Care and Strategy Practices. Dr. Chang currently serves as an Observer on the Boards of Biodesy, Cleave Biosciences, Crinetics Pharmaceuticals and Ideaya. Before joining 5AM, Dr. Chang was an M.D./Ph.D. Physician Scientist Fellow in the Harvard-MIT Health Sciences and Technology Program and an Ashford Fellow. She completed an internship in Internal Medicine at the Beth Israel Deaconess Medical Center and pursued residency in Ophthalmology at the Massachusetts Eye and Ear Infirmary. Her Ph.D. work at Harvard focused on mammalian stem cell fate determination and was published in the journals Nature and Nature Review Genetics, among others. She holds a B.A. in Chemistry from Princeton University, a Ph.D. in Biophysics from Harvard University and an M.D. from Harvard Medical School. Dr. Chang is based in the San Francisco, CA office.